DKDRF (NewMed Energy LP) Research & Development: $0.0 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DKDRF NewMed Energy LP DKDRF
71 GF Score
Price $5.58
GF Value $2.87
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is NewMed Energy LP Research & Development?

NewMed Energy LP DKDRF +9.04% 71 Research & Development is $0.0 Mil as of Mar. 2026. GuruFocus rates DKDRF with a GF Score™ of 71/100 and a GF Value™ of $2.87 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. NewMed Energy LP's Research & Development for the three months ended in Mar. 2026 was $0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $0.0 Mil.

NewMed Energy LP  (OTCPK:DKDRF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

NewMed Energy LP Research & Development Related Terms

NewMed Energy LP Research & Development Historical Data

* Premium members only.

The historical data trend for NewMed Energy LP's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NewMed Energy LP Research & Development Chart

NewMed Energy LP Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

NewMed Energy LP Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
DKDRF
71GF Score
NewMed Energy LP DKDRF
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NewMed Energy LP Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.0 Mil mean?
NewMed Energy LP (DKDRF) has a Research & Development of $0.0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on NewMed Energy LP and its competitors.
Is NewMed Energy LP's Research & Development too high?
NewMed Energy LP's current Research & Development is $0.0 Mil. Overall, NewMed Energy LP has a GF Score™ of 71/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does NewMed Energy LP's Research & Development compare to COP and EOG?
NewMed Energy LP's Research & Development of $0.0 Mil can be compared against companies in the Oil & Gas industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Oil & Gas company?
A good Research & Development depends on the Oil & Gas industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on NewMed Energy LP and its competitors. NewMed Energy LP's current Research & Development is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NewMed Energy LP stock overvalued right now?
Based on GuruFocus' analysis, NewMed Energy LP (DKDRF) is currently considered Significantly Overvalued. The stock's GF Value™ is $2.87, compared to a current price of $5.58 — trading 94.4% above its estimated fair value. The current Research & Development is $0.0 Mil. NewMed Energy LP's overall GF Score™ is 71/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For NewMed Energy LP (DKDRF), the current Research & Development is $0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is NewMed Energy LP (DKDRF) Overvalued in 2026?

Based on GuruFocus' analysis, NewMed Energy LP stock appears to be overvalued. The current stock price of $5.58 is trading 94.4% above its estimated GF Value™ of $2.87. GuruFocus considers NewMed Energy LP to be Significantly Overvalued.

Key valuation signals for DKDRF:

  • Research & Development: $0.0 Mil
  • GF Value™: $2.87 vs. price of $5.58 (94.4% above fair value)
  • GF Score™: 71/100 with 4 warning signs

No single metric tells the full story. See the DKDRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

NewMed Energy LP Business Description

Industry EnergyOil & Gas
Other Exchanges NWMD:Israel
Address 19 Abba Even Boulevard, Hertzliya Pituach, Hertzliya, ISR, 4672537
NewMed Energy LP operates in the energy field. Its primary business is exploring, developing, producing, and marketing natural gas, condensate, and oil in Israel and Cyprus and promoting various natural gas-based projects. The Partnership aims to increase the volume of its natural gas sales.
71GF Score

Get the complete analysis for DKDRF

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.58
Price
$2.87
GF Value